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Abstract
Some patients with severe mental disorders
are refractory to psychotherapeutic or psy-
chopharmacological interventions. We present
a patient who at the age of 19 developed sever-
al schizophrenia - suspect symptoms. Soon
inexplicable general seizures where observed.
He was treated with antipsychotics, but had
two bouts of malignant neuroleptic syndrome.
Electroconvulsive therapy (ECT) gave some
symptom relief and he continued on mainte-
nance ECT for years with weekly intervals.
Interruption of this treatment pattern rapidly
increased symptom load. After seven years a
lorazepam provocation test was performed as
he had a new relapse after 3 weeks without
ECT. In the ensuing hours his aggressiveness
and nonsense speaking rapidly diminished.
Kahlbaums observation of seizures as part of a
catatonia was not understood in this case. The
publication of the new DSM-V diagnosis of
catatonia may hopefully reduce the probability
of treating a patient for schizophrenia for
years without access to a more targeted med-
ication and ECT plan. 
Introduction
Patients not responding to psychotropic
medication are a challenge for psychiatrists
and facility staff. The burden on the families of
the patients is not only emotional, but also a
financial one.1,2 Some of these patients, with
affective symptoms and more schizophreni-
form symptoms as part of the primary diagnos-
tic entity, may be helped by electroconvulsive
treatment (ECT). This was already shown in a
paper penetrating the medical records of the
first series of patients treated by Meduna in
Budapest, albeit with camphor.3 Rabheru and
Persad reviewed the literature on continuation
and maintenance electroconvulsive therapy in
different patient groups in 1997.4 The efficacy
of maintenance ECT has recently been shown
in a study of major depression.5 They conclud-
ed that both continuation and maintenance
electroconvulsive therapy were efficacious,
safe, well tolerated, and also cost-effective for
patients with major psychiatric disorders with
depression. The procedure in itself is deemed
extremely safe according to Nuttal et al. who
studied 2279 patients given 17,394 ECT treat-
ments.6 No deaths were observed, and only
transient cardiac complications (arrhythmias
and one cardiac arrest) in 9 patients. The
adverse effects of ECT are related to the anaes-
thesia, which today is very short and practical-
ly without any danger of mortality. Headache
and nausea occur in some patients, and tran-
sient memory impairment is usual during the
time of a series of ECTs. 
The indications for ECT around the world
differ, although the main indication is severe
depression, uni- or bipolar or as part of other
mental illnesses.7 Also manic episodes and
catatonia without schizophrenia do respond
favourably to ECT. Thus it would be of interest
to report on the treatment of a patient with
severe mental illness, purportedly diagnosed
as schizophrenia, given ECT for more than
seven years. 
Case Report
We describe a patient with severe symptoms
from the age of 20. His illness started during
military service in 1973. The military doctor
observed that he suddenly one day was sitting
under military training staring, answering
only yes or no. He was referred to the psychi-
atric asylum on chlorpromazine 50 mg twice
daily. In the asylum his illness was described
as catatonic episodes or a parkinsonistic cri-
sis. Shortly after arrival he had a general
seizure and later minor seizures. The first
week he was mute with a stupor. After one
week he responded to other people and after
three weeks he was sent home on 4 mg
haloperidol. For 12 years he lived a fairly nor-
mal life with work and non-resident contact
with a psychiatrist. Some episodes of depres-
sion were observed. He was maintained on
small doses of different antipsychotics. Before
the next resident stay he had taken contact
with Hare Krishna groups, giving him a state
of incoherent speech and agitation. Again he
had general seizures of 2-3 minutes duration.
EEG was normal. This time he was treated with
the following medication: Haloperidol 40 mg,
levomepromazin 300 mg, perfenazin 32 mg
and orfenadrin 200 mg per die. In 1995 he
probably had neuroleptic malignant syndrome
(NMS) and was treated in a somatic depart-
ment. 2006 he had several grand mal seizures
and a new serious episode of NMS. After this
episode ECT was started and already at the 6th
treatment he was deemed to be normal. He
showed no sign of a psychotic disease.
Maintenance ECT was not started and after
some months he was again referred to the hos-
pital and was in need of 10 ECT treatments
before he remitted. 2007 he started with regu-
lar ECT at two weeks intervals, later the inter-
vals have changed and before the latest refer-
ral he was on ECT once weekly. He recently
dropped out of the regular, scheduled ECT for
three weeks and he relapsed with involuntary
movements and incoherent speech.  His agitat-
ed stait precluded an orderly ECT procedure. 
A lorazapam challenging test with only 1 mg
orally was given because the department did
not have injectables. His motor unrest and
incoherent speech improved after a couple of
hours. He was put on lorazepam 1 mg thrice
daily and ECT could again be given after two
days. He was after four/five treatments again
able to communicate and respond normally.
When asked about his memory he had no com-
plaints after all these years with ECT. He main-
tained he recalled as well as his compatriots at
home. Electroconvulsive treatment: procedure 
ECT is performed in dedicated rooms in the
acute psychiatric department with an anaes-
thesiologist and anaesthetic nurse present.
The treatment is given with a Thymatron IVTM
device. Two EEG leads and pulse oxymeter
readings are registered together with ECG and
the calculated output from the Thymatron
device. A nurse surveys the patient after the
treatment. Most of his treatments have been
as a non-resident patient coming to the hospi-
tal only for the sessions. The treatments have
been given with right unilateral stimulating
electrode placement with 90-100% stimulation
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level. He has to date received 350 ECT treat-
ments. Anesthesia
Three hundred mg thiopental and 60 mg
succinylcholine has been used over the years.
Premedication with glycopyrron 0.2 mg. 
Discussion and Conclusions
The present case demonstrates the impor-
tance of a thorough clinical diagnosis in
patients with changing stupor and mutism,
florid megalomanic and muscular symptoms.
The seizures as observed already by Karl
Ludwig Kahlbaum after 1863 may be a signal of
the disease of catatonia in an early stage.8 The
use of lorazepam is both a diagnostic tool and
a treatment supplement besides ECT when the
patient suffers from catatonia.9 Treatment
with ECT over many years may influence mem-
ory and cognition, but the severity differs
greatly. Malignant neuroleptic syndrome in
this patient reduced the possible cognitive
reduction from medication.10 His definite
improvement would be a positive input in the
vivid on-going discussion by lay people and
psychologist/psychiatrists on cognitive deficits
after ECT.11-17 It is still disputed in the litera-
ture, less among clinicians, whether ECT as a
maintenance option is effective. The NICE
guidelines (National Institute of Clinical
Excellence, technology appraisal 59) from 2003
are negative, but their conclusion is based on
mostly retrospective reports, and not the fol-
lowing study. In a prospective, controlled study
Swoboda et al. studied a group of patients
(N=42) with affective or schizoaffective disor-
der.18 They got either maintenance ECT +
pharmacotherapy or pharmacotherapy alone.
At 12 months the former group had a rehospi-
talisation rate of 33% whereas the latter had
67%. Time to relapse was also longer in the
ECT group. The results were somewhat poorer
for the schizoaffective cases. Frequent mainte-
nance ECT, as in our patient, may keep the
incumbent out of hospital. The NICE guide-
lines conclusion may thus be irrelevant in
these special patients as mentioned in the
most recent textbook on ECT.19 And in a case
as the present, with catatonia, evidence for the
positive effect of ECT with or without the use
of lorazepam is forthcoming. 
The outcome years after a series of ECT may
in many cases not be very different from other
short-term treatment options as pharma-
cotherapy and/or psychotherapy for depres-
sions.20 Our patients are influenced by social,
economic and emotional factors after success-
ful ECT. These factors would mostly not be
related to the ECT as such. Helping patients
develop skills to cope with lifea and are neces-
sary would be a task for other health profes-
sionals than those administering the treat-
ment. In a small follow up study after ECT
some patients committed suicide long time
after the end of the series.21 The patients had
serious problems with coping in life as
assessed by the Sense of Coherence test of
Antonovsky.22 Long-term maintenance treat-
ment may thus contribute to a lower mortality
rate in severely depressed patients. The pres-
ent patient finally got a proper diagnosis after
experiencing NMS twice and thus forcing his
clinicians to offer him ECT. This could have
been realised at a much earlier time point in
his illness. 
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